Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
(NASDAQ: LTRN) Delayed: 1.77 -0.07 (3.8%)
Previous Close $1.84    52 Week High
Open $1.82    52 Week Low
Day High $1.86    P/E N/A 
Day Low $1.76    EPS
Volume 180,722